Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.5200
- TODAY'S CHANGE (%)0.0100 (0.6623%)
- Bid / Lots1.5100/ 2
- Ask / Lots1.5200/ 3
- Open / Previous Close1.5250 / 1.5100
- Day Range
- 52 Week Range
- Volume48,227
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:34 ET | 535 | 1.525 |
| 09:54 ET | 100 | 1.52 |
| 10:01 ET | 9539 | 1.515 |
| 10:08 ET | 200 | 1.52 |
| 10:10 ET | 4958 | 1.5101 |
| 10:14 ET | 657 | 1.515 |
| 10:19 ET | 200 | 1.515 |
| 10:28 ET | 147 | 1.51 |
| 10:30 ET | 100 | 1.5197 |
| 10:37 ET | 1876 | 1.52 |
| 10:48 ET | 331 | 1.511 |
| 10:50 ET | 1900 | 1.5468 |
| 10:51 ET | 300 | 1.5244 |
| 11:13 ET | 3200 | 1.5399 |
| 11:15 ET | 2012 | 1.53 |
| 11:36 ET | 400 | 1.5201 |
| 12:25 ET | 200 | 1.533 |
| 12:27 ET | 2105 | 1.53 |
| 12:30 ET | 133 | 1.5388 |
| 12:36 ET | 1000 | 1.525 |
| 12:54 ET | 100 | 1.53 |
| 01:24 ET | 6732 | 1.52 |
| 01:32 ET | 2292 | 1.52 |
| 01:33 ET | 1100 | 1.52 |
| 01:48 ET | 259 | 1.52 |
| 01:50 ET | 506 | 1.52 |
| 02:04 ET | 100 | 1.5209 |
| 02:08 ET | 250 | 1.525 |
| 02:11 ET | 100 | 1.53 |
| 02:13 ET | 400 | 1.5201 |
| 02:20 ET | 400 | 1.53 |
| 02:42 ET | 3000 | 1.5166 |
| 02:49 ET | 200 | 1.5119 |
| 02:56 ET | 100 | 1.51 |
| 03:14 ET | 900 | 1.52 |
Sep 24, 2024
Milestone Pharmaceuticals to Host Investor KOL Event, from 8:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 6, 2024
Sep 4, 2024
Press Release: Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow JonesMilestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
Milestone(R) Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference, from 8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 80.4M | -1.5x | --- |
Vistagen Therapeutics Inc | 81.2M | -2.0x | --- |
Ovid Therapeutics Inc | 79.5M | -2.8x | --- |
Chimerix Inc | 81.0M | -0.9x | --- |
Beyondspring Inc | 82.6M | -5.5x | --- |
Sellas Life Sciences Group Inc | 81.7M | -1.4x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer, Director
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $80.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-1.01 |
Book Value | $0.50 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
